
Rachna Shroff MD M.S.
Gastrointestinal Cancer
Chief, Division of Hematology/Oncology Associate Director, Clinical Investigations, University of Arizona Cancer Center (UACC) Associate Dean, Clinical and Translational Research, UA College of Medicine - Tucson Professor of Medicine
Join to View Full Profile
3838 N Campbell Ave Unit 10Tucson, AZ 85719
Phone+1 314-853-1185
Dr. Shroff is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2007 - 2010
- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2004 - 2007
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2004
Certifications & Licensure
- AZ State Medical License 2018 - 2025
- TX State Medical License 2007 - 2024
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Atezolizumab + Cabozantinib in Patients W/ Metastatic, Refractory Pancreatic Cancer Start of enrollment: 2021 Oct 12
Roles: Principal Investigator, Contact
- Immune Response to the COVID-19 Vaccine Start of enrollment: 2021 Jun 07
- Gemcitabine and Cisplatin With or Without CPI-613 as First Line Therapy for Patients With Advanced Unresectable Biliary Tract Cancer (BilT-04) Start of enrollment: 2020 Jun 23
Roles: Contact, Principal Investigator
- Join now to see all
Publications & Presentations
PubMed
- Distinct Molecular and Clinical Features of Specific Variants of KRAS Codon 12 in Pancreatic Adenocarcinoma.Bach Ardalan, Aaron Ciner, Yasmine Baca, Andrew Hinton, Sourat Darabi
Clinical Cancer Research. 2025-03-17 - Clinical outcomes and molecular characteristics of lung-only and liver-only metastatic pancreatic cancer: results from a real-world evidence database.Abrahm Levi, Edik Blais, John Davelaar, Matthew I Ebia, Angela Minasyan
The Oncologist. 2025-03-10 - A phase III randomized study of first-line NUC-1031/cisplatin vs. gemcitabine/cisplatin in advanced biliary tract cancer.Jennifer J Knox, Mairéad G McNamara, Igor S Bazin, Do-Youn Oh, Oleksii Zubkov
Journal of Hepatology. 2025-02-18
Press Mentions
- Arizona Doctor Recalls Living Out Her Red Carpet Oscars FantasyMarch 3rd, 2025
- U of a Cancer Center’s Clinical Trial Pioneers New Advances in Biliary Tract Cancer TreatmentJanuary 16th, 2025
- Miniature Organs Driving Precision Medicine and New Drug DiscoveryApril 21st, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: